The novel coronavirus outbreak has exposed a lack of global research on ways to combat the spread of infectious diseases, with health authorities failing to learn lessons from previous flare-ups, experts said Tuesday.
The last outbreak of worldwide signficance was the SARS virus scare of the early 2000s, which killed 774 people. More recently the Mers virus killed more than 850 people, although the outbreak was largely contained to the Middle East.
Although scientists responded to both diseases, formulating treatment plans and eventually vaccines, experts say the new coronavirus epidemic shows there has not been any sustained, coordinated efforts on infectious diseases.
"Too often, the surge of research attention and investment that novel outbreaks generate quickly wane when those outbreaks subside and other priorities take their place," Jason Schwartz, assistant professor at Yale's Department of Health Policy and Management, told AFP.
"SARS and Mers demonstrated the global health threat posed by coronaviruses and the need for a sustained investment in better understanding these viruses with a eye toward prevention and treatment strategies."
But the financial crisis of 2008 squeezed out funding, he said, lamenting a "scientific world on financial life support."
"We missed an opportunity. It's a terrorist attack of a virus which we could have prevented, more people are going to die, it's really a shame."
"You need to have clinical trials and for that you need people who are sick with the virus."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
